This weight-loss hormone may protect the liver without weight loss.
Recently, there have been several recent developments in the field of international medical health that continue to attract the attention of the industry and the public. Researchers at the University of Maccam have discovered an unexpected hormone that is known to reduce appetite and support weight loss. The hormone appears to protect the liver from inflammation through previously unknown signaling pathways, a finding that may point to a new approach to treating late-stage obese hepatitis.
A study published in the Journal of Cell Metabolism, June 10, 2026, found that GDF15 (growth factor β15) can reduce liver inflammation and alleviate the formation of intra-hepatic scarring even without weight gain. This result challenged the long-held idea that the benefits of hormones are primarily related to their ability to affect appetite and weight. The new goal: metabolically-associated hepatic sclerosis (MASH, an advanced form of fatty liver) new drugs: new drugs to help improve the medical outcome of many patients, but liver inflammation may still persist even with significant weight loss.
By identifying the biological pathways that directly regulate this inflammation, new findings suggest that possible future therapies may be able to treat both liver inflammation and existing treatments for weight and liver fat. Our study found that GDF15 functions far beyond regulating appetite and weight. We found that GDF15 activates a natural brain-to-liver signaling pathway that helps suppress hepatitis inflammation and reduce fibrosis.
The team used clone mice (C57BLW) designed to be highly similar to the human MASH model to study the effects of GDF15 on severe liver damage in these mice. Through extracorporeal experiments, the team revealed that GDF15 was used to regulate the expression of cytokines (such as TNF-α, IFN-γ) in the early stages of liver damage, and to intervene in the severity of liver damage by regulating the expression of cytokines, thereby protecting liver cells and preventing further aggravation of liver damage. Researchers combined genetics, pharmacology, genomics, and spatial gene transcription techniques to study what happens when hormones are active.
They found that GDF15 initiated the brain's signaling through the nervous system, ultimately leading to the release of thyroid hormones. These hormones were important in metabolism, immune activity, and the body's response to stress. Then, corticosteroids helped suppress liver inflammation.
Importantly, the researchers observed these protective effects. If you have any health questions, please consult a professional medical professional.
